Cyclica (acquired by Recursion, Nasdaq: RXRX) reposted this
Recursion announced an incredible achievement today. Using NVIDIA’s DGX Cloud and our own NVIDIA-based supercomputer, BioHive-1, Recursion bridged the protein and chemical space by predicting the protein target(s) for ~36 billion compounds in the Enamine Ltd. REAL Space. I am personally so excited about this. 🚀 💊 For many years at Cyclica we aspired to achieve this large scale match of the chemical universe to the protein universe. In fact, at Cyclica our mission was to “Open new frontiers in drug discovery by matching the chemical universe to the entire protein universe”. I’m so glad to see this come to reality - one of many examples underpinning the strength of the strategic partnership between Recursion and Cyclica. And we're only getting started. Kudos to Chris Gibson, Ben Mabey, Imran Haque, Stephen MacKinnon and everyone involved in this project - what a giant leap forward. Learn more: https://lnkd.in/gaBFrCat This announcement follows a number of exciting developments across our technology, pipeline and partnerships over the past several months, which we reported today in our Q2 business updates and financial results. Learn more: https://lnkd.in/gF8uWrtv #biotech #drugdiscovery #machinelearning #artificialintelligence #alphafold #chemistry #polypharmacology
